Serum pepsinogens in gastric cancer screening.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Combination of Serum Test and Questionnaire in Early Gastric Cancer Screening.Iranian journal of public health · 2022
   Article
2. Molecular Alterations in Gastric Intestinal Metaplasia.International journal of molecular sciences · 2021
   Review
3. Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection.Cancer epidemiology · 2020
   Article
4. Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormones.Gastroenterology research · 2019
   Review
5. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.Alimentary pharmacology & therapeutics · 2018
   Article
6. Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2016
   Article
7. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.Gut · 2016
   Article
8. Potential prognostic, diagnostic and therapeutic markers for human gastric cancer.World journal of gastroenterology · 2014
   Review
9. Screening for and surveillance of gastric cancer.World journal of gastroenterology · 2014
   Review
10. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2011
    Review

Corrections and comments

• Comment on
  Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histologic risk index.2010

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as